Treatment planning for patients with autism spectrum disorders

Journal of Clinical Psychiatry

Volumn 66, Issue SUPPL. 10, 2005, Pages 38-45

  Aman, Michael G ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; ADENYLOSUCCINATE LYASE; CASEIN; CHIRHOSTIM; DIHYDROPYRIMIDINE DEHYDROGENASE; DIMETHYLGLYCINE; DNA; ENDORPHIN; ESSENTIAL FATTY ACID; FAMOTIDINE; FLUXID; GLUTEN; MAGNESIUM; PHENYLALANINE; PHENYLALANINE 4 MONOOXYGENASE; PYRIDOXINE DERIVATIVE; RETINOL; RIBOSEPHOSPHATE PYROPHOSPHOKINASE; SECREMAX; SECRETIN;

ALTERNATIVE MEDICINE; ASPERGER SYNDROME; AUDIOLOGY; AUTISM; BEHAVIOR MODIFICATION; BEHAVIOR THERAPY; BEHAVIORAL SCIENCE; BLISTER; CHELATION; CLINICAL FEATURE; CLINICAL TRIAL; COMMUNICATION DISORDER; DISABILITY; EARLY INTERVENTION; FACILITATED COMMUNICATION; GASTROINTESTINAL SYMPTOM; GENETIC COUNSELING; GLUTEN FREE DIET; HEARING; HOUSING; HUMAN; INTELLIGENCE QUOTIENT; LAW; MASTURBATION; METABOLISM; MUSIC; OCCUPATIONAL THERAPY; PARENT; POLYNEUROPATHY; PRIORITY JOURNAL; PRIVACY; REVIEW; SEXUALITY; SOCIAL INTERACTION; SPECIAL EDUCATION; SPEECH THERAPY; TRAINING; TREATMENT PLANNING;

AGE FACTORS; ATTITUDE OF HEALTH PERSONNEL; AUTISTIC DISORDER; CHILD; COUNSELING; DEVELOPMENTAL DISABILITIES; EDUCATION, SPECIAL; FAMILY HEALTH; HUMANS; LANGUAGE THERAPY; PATIENT CARE PLANNING; SOCIAL ADJUSTMENT; SOCIAL SUPPORT; SPEECH THERAPY; TREATMENT OUTCOME; UNITED STATES;

EID: 31144452409     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994
2. Lecavalier L. Behavior and emotional problems in young people with pervasive developmental disorders: relative prevalence, effects of subject characteristics, and empirical classification. J Autism Dev Disord. In press
3. Lainhart JE. Psychiatric problems in individuals with autism, their parents and siblings. Int Rev Psychiatry 1999;11:279-298
4. Baranek GT. Efficacy of sensory and motor interventions for children with autism. J Autism Dev Disord 2002;32:397-422
5. Volkmar F, Cook E Jr, Pomeroy J, et al. Practice parameters for the assessment and treatment of children, adolescents, and adults with autism and other pervasive developmental disorders. J Am Acad Child Adolesc Psychiatry 1999;38:32S-54S
6. Committee on Children With Disabilities. The pediatrician's role in the diagnosis and management of autistic spectrum disorder in children. Pediatrics 2001;107:1221-1226
7. Committee on Children With Disabilities. Technical report: the pediatrician's role in the diagnosis and management of autistic spectrum disorder in children. Pediatrics 2001;107:e85
8. Quality Standards Subcommittee of the American Academy of Neurology and Child Neurology Society. Practice parameter: screening and diagnosis of autism: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Child Neurology Society. Neurology 2000;55:468-479
9. Filipek PA, Accardo PJ, Baranek GT, et al. The screening and diagnosis of autistic spectrum disorders. J Autism De v Disord 1999;29:439-484
10. Bondy AS, Frost L. PECS: potential benefits and risks. Behav Analyst Today 2001:2:127-132
11. Frost L, Bondy AS. The Picture Exchange Communication System. Cherry Hill, NJ: Pyramid Educational Consultants; 1994
12. Bondy AS, Frost LA. The picture exchange communication system. Semin Speech Lang 1998;19:373-389
13. Morrison L, Kamps D, Garcia J, et al. Peer mediation and monitoring strategies to improve initiations and social skills for students with autism. J Pos Behav Interventions 2001;3:237-250
14. Roeyers H. The influence of nonhandicapped peers on the social interactions of children with a pervasive developmental disorder. J Autism Dev Disord 1996;26:303-320
15. Gray C, White AL. My Social Stories Book. Philadelphia, Pa: Jessica Kingsley; 2003
16. Koegel LK, Koegel RL, Shoshan Y, et al. Pivotal response intervention, 2: preliminary long-term outcome data. J Assoc Child Severe Handicap 1999;24:186-198
17. Levy SE, Hyman SL. Use of complementary and alternative treatments for children with autism spectrum disorders is increasing. Pediatr Ann 2003;32:685-691
18. Lecavalier L, Leone S, Wiltz J. The impact of behaviour problems on caregiver stress in young people with autism spectrum disorders. J Intellect Disabil Res. In press
19. Berkman M. Handbook of Autism and Pervasive Developmental Disorders. New York, NY: John Wiley & Sons, Inc; 1997:808-827
20. Committee on Educational Interventions for Children With Autism. Educating Children With Autism. Washington, DC: National Academy Press; 2001
21. Page T. Metabolic approaches to the treatment of autistic spectrum disorders. J Autism Dev Disord 2000;30:463-469
22. Shevell M, Ashwal S, Donley D, et al. Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Practice parameter: evaluation of the child with global developmental delay: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 2003;60:367-380
23. Mirenda P. Toward functional augmentative and alternative communication for students with autism: manual signs, graphic symbols, and voice output communication aids. Lang Speech Hear Serv Sch 2003;34:203-216
24. Butter EM, Wynn J, Mulick JA. Early intervention critical to autism treatment. Pediatr Ann 2003;32:677-684
25. Jacobson JW, Mulick JA, Green G. Cost-benefit estimates for early intensive behavioral intervention for young children with autism: general model and single state case. Behav Interventions 1998;13:201-206
26. US Department of Health and Human Services. Mental Health: A Report of the Surgeon General. Rockville, Md: US Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Center for Mental Health Services, National Institutes of Health, National Institute of Mental Health; 1999
27. Kabot S, Masi W, Segal M. Advances in the diagnosis and treatment of autism spectrum disorders. Prof Psychol 2003;34:26-33
28. Marcus LM, Kunce LJ, Schopler E. Working With Families: Handbook of Autism and Pervasive Developmental Disorders. New York, NY: John Wiley; 1997:631-649
29. Aman MG, Lam KL, Collier-Crespin A. Prevalence and patterns of psychoactive medicines among individuals with autism in the Autism Society of Ohio. J Autism Dev Disord 2002;33:527-534
30. Aman MG, Lam KSL, Van Bourgondien ME. Medication patterns in patients with autism: temporal, regional, and demographic influences. J Child Adolesc Psychopharmacol 2005;15:116-126
31. Langworthy-Lam KL, Aman MG, Van Bourgondien ME. Prevalence and patterns of use of psychoactive medicines in individuals with autism in the Autism Society of North Carolina. J Child Adolesc Psychopharmacol 2002;12:311-321
32. Ohio Department of Health, Bureau for Children With Medical Handicaps. Autism. Reaching for a Brighter Future. Service Guidelines for Individuals With Autism Spectrum Disorder/Pervasive Developmental Disorder (ASD/PDD). Birth Through Twenty-One. Columbus, Ohio: Ohio Developmental Disabilities Council; 2004
33. Gerhardt PF, Holmes DL. Employment: options and issues for adolescents and adults with autism, In: Cohen DJ, Volkmar FR, eds. Handbook of Autism and Pervasive Developmental Disorders. New York, NY: John Wiley; 1997:650-664
34. Mostert MP. Facilitated communication since 1995: a review of published studies. J Autism Dev Disord 2001;31:287-313
35. Jacobson JW, Mulick JA, Schwarte AA. A history of facilitated communication: science, pseudoscience, and anti-science. Am Psychol 1995;50:750-765
36. Green G. The quality of the evidence. In: Shane HC, ed. Facilitated Communication: The Clinical and Social Phenomenon. San Diego, Calif: Singular Publishing; 1994:157-226
37. Simpson RL, Myles BS. Effectiveness of facilitated communication with children and youth with autism. J Spec Educ 1995;28:424-439
38. Kern JK, Espinoza E, Trivedi MH. The effectiveness of secretin in the management of autism. Expert Opin Pharmacother 2004;5:379-387
39. Sturmey P. Secretin is an ineffective treatment for pervasive developmental disabilities: a review of 15 double-blind randomized controlled trials. Res Dev Disabil 2005;26:87-97
40. Sinha Y, Silove N, Wheeler D, et al. Auditory integration training and other sound therapies for autism spectrum disorders. In: The Cochrane Library; issue 1. Chichester, UK: John Wiley & Sons, Ltd; 2004
41. Aman MG, Singh NN. Patterns of drug use, methodological considerations, measurement techniques, and future trends. In: Aman MG, Singh NN. Psychopharmacology of the Developmental Disabilities. New York, NY: Springer-Verlag; 1988:1-28
42. Singh NN, Ellis CR, Mattila MJ, et al. Vitamin, mineral, and dietary treatments. In: Reiss S, Aman MG, eds. Psychotropic Medications and Developmental Disabilities: The International Consensus Handbook. Columbus, Ohio: The Ohio State University Nisonger Center; 1998:311-320
43. Findling RL, Maxwell K, Scotese-Wojtila L, et al. High-dose pyridoxine and magnesium administration in children with autistic disorder: an absence of salutary effects in a double-blind, placebo-controlled study. J Autism Dev Disord 1997;27:467-478
44. Nye C, Brice A. Combined vitamin B6-magnesium treatment in autism spectrum disorder. Cochrane Database Syst Rev 2004;2. Available at: http://gateway.ut.ovid.com/gw2/ovidweb.cgi. Accessed February 3, 2005
45. Garvey J. Diet in autism and associated disorders. J Fam Health Care 2002;12:34-38
46. Knivesberg AM, Reichelt KL, Noødland M. Reports on dietary intervention in autistic disorders. Nutr Neurosci 2001;4:25-37
47. Millward C, Ferriter M, Calver S, et al. Gluten- and casein-free diets for autistic spectrum disorder. Cochrane Database Syst Rev 2004;4. Available at: http://gateway.ut.ovid.com/gw2/ovidweb.cgi. Accessed February 3, 2005
48. Dawson G, Watling R. Interventions to facilitate auditory, visual, and motor integration in autism: a review of the evidence. J Autism Dev Disord 2000;30:415-421